These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4989813)

  • 21. Clinical and pharmacologic experience with dibromodulcitol (NSC-104800). A new antitumor agent.
    Sellei C; Eckhardt S; Horváth IP; Kralovánszky J; Institóris L
    Cancer Chemother Rep; 1969 Dec; 53(6):377-84. PubMed ID: 4915082
    [No Abstract]   [Full Text] [Related]  

  • 22. Irreversible enzyme inhibitors. 173. Cure of Walker 256 ascites by reversible and irreversible inhibitors of dihydrofolic reductase derived from 1-(substituted-phenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
    Baker BR; Vermeulen NM; Ashton WT; Ryan AJ
    J Med Chem; 1970 Nov; 13(6):1130-40. PubMed ID: 5479852
    [No Abstract]   [Full Text] [Related]  

  • 23. Potential antitumor agents. Some 1,6-disubstituted galactitol and mannitol derivatives.
    Acton EM; Keyanpour-Rad M; Christensen JE; Tong HH; Kwok RP; Goodman L
    Carbohydr Res; 1972 May; 22(2):477-86. PubMed ID: 5047748
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. VII.
    Venditti JM; Sheldon DR; Goldin A
    Cancer Res; 1964 Jan; 24(1 Pt 1):145-210. PubMed ID: 5878215
    [No Abstract]   [Full Text] [Related]  

  • 25. Potential anticancer agents. 3. Schiff bases from benzaldehyde nitrogen mustards and aminophenylthiazoles.
    Modi JD; Sabnis SS; Deliwala CV
    J Med Chem; 1970 Sep; 13(5):935-41. PubMed ID: 5458385
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical pharmacology of dibromohexitols.
    Eckhardt S
    Haematologica; 1972 Apr; 57(11):722-31. PubMed ID: 4200307
    [No Abstract]   [Full Text] [Related]  

  • 27. Antineoplastic substances from the sea: a review.
    Li CP; Goldin A; Hartwell JL
    Cancer Chemother Rep 2; 1974 Jul; 4(3):97-129. PubMed ID: 4367172
    [No Abstract]   [Full Text] [Related]  

  • 28. Dibromomannitol (NSC-94100): a clinical study of previously treated patients with refractory chronic myelocytic leukemia and blastic transformation.
    Levin WC; Mims CH; Haut A
    Cancer Chemother Rep; 1974; 58(2):223-8. PubMed ID: 4598242
    [No Abstract]   [Full Text] [Related]  

  • 29. 1,3,2-dioxaphosphorinane 2-oxides. IV. Preparation of some 2-substituted-5-carbomethoxy-5-methyl-1,3,2-dioxaphosphorinane 2-oxides as potential antitumor agents.
    Billman JH; Roehrig GR
    J Pharm Sci; 1970 Jun; 59(6):861-3. PubMed ID: 5423097
    [No Abstract]   [Full Text] [Related]  

  • 30. Antineoplastic agents. 41. The beetle Allomyrina dichotomus.
    Pettit GR; Ode RH
    Lloydia; 1976; 39(2-3):129-33. PubMed ID: 948237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential anticancer agents. XXII. Pharmacological properties of some new triazene derivatives.
    Ionescu D; Neagu V; Dobre V; Niculescu-Duvaz I
    Neoplasma; 1981; 28(1):19-26. PubMed ID: 7279057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antineoplastic components of marine animals.
    Pettit GR; Day JF; Hartwell JL; Wood HB
    Nature; 1970 Aug; 227(5261):962-3. PubMed ID: 4393654
    [No Abstract]   [Full Text] [Related]  

  • 33. Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice.
    Neil GL; Wiley PF; Manak RC; Moxley TE
    Cancer Res; 1970 Apr; 30(4):1047-54. PubMed ID: 5504347
    [No Abstract]   [Full Text] [Related]  

  • 34. Porfiromycin (NSC-56410)--clinical brochure.
    Carter SK
    Cancer Chemother Rep 3; 1968 Dec; 1(1):81-97. PubMed ID: 4989816
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on leukemia L1210.
    Mihich E; Mulhern AI
    Cancer Res; 1968 Feb; 28(2):354-62. PubMed ID: 5641525
    [No Abstract]   [Full Text] [Related]  

  • 36. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
    Chabner BA; Chello PL; Bertino JR
    Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
    [No Abstract]   [Full Text] [Related]  

  • 37. Some 6-substituted nicotinamides: synthesis and antineoplastic activities.
    Ross WC
    Biochem Pharmacol; 1967 Apr; 16(4):675-80. PubMed ID: 4226739
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models].
    Gutsche W; Schulze W; Jungstand W; Wohlrabe K
    Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic and pharmacokinetic measurements of antitumor agents.
    Mellett LB
    Clin Pharmacol Ther; 1974 Jul; 16(1):230-42. PubMed ID: 4210526
    [No Abstract]   [Full Text] [Related]  

  • 40. 4-(1-adamantyl)-3-thiosemicarbazones as potential chemotherapeutic agents.
    Prescott B; Lones G; Peacock CL; Caldes G
    Antimicrob Agents Chemother (Bethesda); 1969; 9():275-9. PubMed ID: 5396501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.